Trimodal Cancer Therapy
Cancers are treated with three types of agents: a chemotherapeutic agent which induces lymphopenia; an inhibitory antibody to a surface marker on Treg cells; and an anti-cancer vaccine. This combination may lead to enhanced immune responses despite lymphodepletion.
Patents:US 20,110,135,637
Inventor(s):
SAMPSON JOHN H [US]; MITCHELL DUANE A [US]; FECCI PETER E [US]
Type of Offer:
Licensing
« More Biotech Patents